📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NMS Group

1.1 - Company Overview

NMS Group Logo

NMS Group

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oncology research and development, managing the integrated R&D chain from pre-clinical to clinical stages. Operates a validated oncology drug discovery platform generating a pipeline of new chemical entities (NCEs).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NMS Group

Jounce Therapeutics Logo

Jounce Therapeutics

HQ: United States Website
  • Description: Provider of first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors, driven by a proprietary product engine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jounce Therapeutics company profile →
Acrivon Therapeutics Logo

Acrivon Therapeutics

HQ: United States Website
  • Description: Provider of precision oncology therapeutics and companion diagnostics, leveraging the AP3 platform to develop drugs and OncoSignature tests that match therapies to tumor-driving mechanisms. Pipeline includes ACR-368, a phase 2 DNA damage response kinase inhibitor for solid cancers, and ACR-2316, a preclinical selective dual WEE1/PKMYT1 inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acrivon Therapeutics company profile →
NanoSmart Pharmaceuticals Logo

NanoSmart Pharmaceuticals

HQ: United States Website
  • Description: Provider of platform drug delivery technologies for solid-tumor cancers, including a human-derived Anti-Nuclear Antibody targeting necrotic tumor tissue, ANA-conjugated lipid nanoparticles for direct API delivery to tumor sites, and a thermally sensitive nanoemulsion enabling stable storage and release at body temperature, plus licensing and partnerships to enhance existing cancer drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoSmart Pharmaceuticals company profile →
Prelude Therapeutics Logo

Prelude Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule cancer therapies and precision antibody-drug conjugates, including PRT3789, a selective SMARCA2 degrader for SMARCA4-deficient tumors; PRT2527, a highly selective CDK9 inhibitor in Phase 1; PRT3645, a next-generation CDK4/6 inhibitor in preclinical studies; and ADCs developed with AbCellera.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prelude Therapeutics company profile →
BiVictriX Therapeutics Logo

BiVictriX Therapeutics

HQ: United Kingdom Website
  • Description: Provider of oncology and haematological malignancy drug discovery and development, biotherapeutics, immunotherapy, and antibody research, specializing in bispecific ADC therapeutics. Offers BVX001, a bispecific ADC targeting CD33/CD7 for Acute Myeloid Leukaemia (AML), and Bi-Cygni Therapeutics, targeting cancer-specific antigen pairs to improve selectivity and reduce toxicity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BiVictriX Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NMS Group

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NMS Group

2.2 - Growth funds investing in similar companies to NMS Group

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NMS Group

4.2 - Public trading comparable groups for NMS Group

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NMS Group

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NMS Group

What does NMS Group do?

NMS Group is a provider of oncology research and development, managing the integrated R&D chain from pre-clinical to clinical stages. Operates a validated oncology drug discovery platform generating a pipeline of new chemical entities (NCEs).

Who are NMS Group's competitors?

NMS Group's competitors and similar companies include Jounce Therapeutics, Acrivon Therapeutics, NanoSmart Pharmaceuticals, Prelude Therapeutics, and BiVictriX Therapeutics.

Where is NMS Group headquartered?

NMS Group is headquartered in Italy.

How many employees does NMS Group have?

NMS Group has 1,000 employees 🔒.

When was NMS Group founded?

NMS Group was founded in 2010 🔒.

What sector and industry vertical is NMS Group in?

NMS Group is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NMS Group

Who are the top strategic acquirers in NMS Group's sector and industry

Top strategic M&A buyers and acquirers in NMS Group's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NMS Group?

Top strategic M&A buyers groups and sectors for NMS Group include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NMS Group's sector and industry vertical

Which are the top PE firms investing in NMS Group's sector and industry vertical?

Top PE firms investing in NMS Group's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NMS Group's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NMS Group's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NMS Group's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NMS Group include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NMS Group's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NMS Group?

The key public trading comparables and valuation benchmarks for NMS Group include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NMS Group for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NMS Group with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NMS Group's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NMS Group with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NMS Group's' sector and industry vertical?

Access recent funding rounds and capital raises in NMS Group's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NMS Group